These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38709848)

  • 21. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
    Senok A; Al-Zarouni M; Al-Najjar J; Nublusi A; Panigrahi D
    J Infect Dev Ctries; 2007 Dec; 1(3):296-302. PubMed ID: 19734608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Anwar S; Nizamuddin S; Malik N; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i76-i87. PubMed ID: 32337594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae.
    Patel JA; Reisner B; Vizirinia N; Owen M; Chonmaitree T; Howie V
    J Pediatr; 1995 May; 126(5 Pt 1):799-806. PubMed ID: 7752010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of Changes to the Clinical and Laboratory Standards Institute
    Humphries R; Bobenchik AM; Hindler JA; Schuetz AN
    J Clin Microbiol; 2021 Nov; 59(12):e0021321. PubMed ID: 34550809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ampicillin-resistant Haemophilus influenzae isolates in Geneva: serotype, antimicrobial susceptibility, and β-lactam resistance mechanisms.
    Cherkaoui A; Diene SM; Emonet S; Renzi G; Francois P; Schrenzel J
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1937-45. PubMed ID: 26187432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.
    Tamma PD; Harris PNA; Mathers AJ; Wenzler E; Humphries RM
    Clin Infect Dis; 2023 Nov; 77(11):1585-1590. PubMed ID: 36001445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions.
    Hirakata Y; Ohmori K; Mikuriya M; Saika T; Matsuzaki K; Hasegawa M; Hatta M; Yamamoto N; Kunishima H; Yano H; Kitagawa M; Arai K; Kawakami K; Kobayashi I; Jones RN; Kohno S; Yamaguchi K; Kaku M
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4225-30. PubMed ID: 19651910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of following National Committee for Clinical Laboratory Standards and Deutsche Industrie Norm-Medizinische Mikrobiologie guidelines, country of isolate origin, and site of infection on susceptibility of Escherichia coli to amoxicillin-clavulanate (Augmentin).
    Simpson I; Durodie J; Knott S; Shea B; Wilson J; Machka K
    J Clin Microbiol; 1998 May; 36(5):1361-5. PubMed ID: 9574706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disc diffusion-based screening tests for extended-spectrum beta-lactamases in Haemophilus influenzae.
    Tristram SG; Bozdogan B; Appelbaum PC
    J Antimicrob Chemother; 2005 Apr; 55(4):570-3. PubMed ID: 15728142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Smayevsky J; Relloso MS; Sucari A; Pennini M; Brilla E; Vilches V; De la Cruz Y; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i43-i59. PubMed ID: 32337593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the adequacy of the antimicrobial therapy of invasive Haemophilus influenzae infections: A pharmacokinetic/pharmacodynamic perspective.
    Ibar-Bariain M; Rodríguez-Gascón A; Isla A; Solinís MÁ; Canut-Blasco A
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Feb; 39(2):65-71. PubMed ID: 32636039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the WIDER I system for antimicrobial susceptibility testing of clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae.
    Fernández-Cuenca F; Martínez-Martínez L; Pascual A; De Cueto M; Gutiérrez O; Nieto J; Perea EJ
    Clin Microbiol Infect; 2003 May; 9(5):449-52. PubMed ID: 12848763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
    O'Halloran C; Walsh N; O'Grady MC; Barry L; Hooton C; Corcoran GD; Lucey B
    Br J Biomed Sci; 2018 Jan; 75(1):24-29. PubMed ID: 29210602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
    Berry V; Hoover J; Singley C; Woodnutt G
    Antimicrob Agents Chemother; 2005 Mar; 49(3):908-15. PubMed ID: 15728883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Van PH; Thinh LQ; Koo SH; Tan SH; Lim PQ; Sivhour C; Lamleav L; Somary N; Sosorphea S; Lagamayo E; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i19-i42. PubMed ID: 32337597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
    Fuchs PC; Barry AL
    J Clin Microbiol; 1994 Nov; 32(11):2846-50. PubMed ID: 7852584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    Torumkuney D; Pertseva T; Bratus E; Dziublik A; Yachnyk V; Liskova A; Sopko O; Malynovska K; Morrissey I
    J Antimicrob Chemother; 2018 Apr; 73(suppl_5):v28-v35. PubMed ID: 29659885
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Merlino J; Rizzo S; English S; Baskar SR; Siarakas S; Mckew G; Fernanado S; Gray T
    Access Microbiol; 2023; 5(10):. PubMed ID: 37970074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.